bad reaction to semaglutide Research published today might leave a taste in your mouth and a crinkle in your nose if you're taking a GLP-1 medication like (the active ingredient in Ozempic and Wegovy) Ozempic (semaglutide) is a GLP-1

Based on the data that 1 in 20 people in the United States are currently taking a GLP-1RA (and assuming a population of 340 million) the number of people affected in the US could be: More than 1 in 10 = at least 3,400,000 1 in 10 to 100 = ~340,000 to 3,400,000 1 in 100 to 1,000 = ~34,000 to 340,000 1 in 1,000 to 10,000 = ~3,400 to 34,000 In the US, GLP-1RAs carry a black box warning to highlight the risk of thyroid C-cell carcinomas (cancer) based on data from rodent studies

HealingMaps may earn a commission when readers sign up through Live Vital

Our clinicians can help review your medical history, baseline labs, medication eligibility, insurance pathway, side-effect concerns, and long-term maintenance plan

Off-Label Weight Loss: Expanded Eligibility While Ozempic isnt FDA-approved specifically for weight loss, doctors frequently prescribe it off-label for weight management